TapewireFind a company

person · Reporting owner

Vitale Lucas

Disclosed activity across 2 companies

Tapewire entity
57250
SEC CIK
0001763869

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
NUVASIVE INCNUVA · Entity 110002Chief Human Resources OfficerMay 07, 2021May 11, 2021
Orthofix Medical Inc.OFIX · Entity 1975CP&BOOMarch 17, 2026March 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

NUVASIVE INC

Report date May 07, 2021 · Filed May 11, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,342 Reported balance After 2021-05-07 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-05-07 · Sale · Disposed 2,208 · Balance 3,342

F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.

F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Filing footnotes · ownership attribution and instrument terms

F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.

F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Orthofix Medical Inc.

Report date March 17, 2026 · Filed March 19, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect160,449 Reported balance After 2026-03-17 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-03-17 · Sale · Disposed 4,269 · Balance 160,449

F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2: Includes 127,256 previously reported restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2: Includes 127,256 previously reported restricted stock units.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 17, 2026 Filed Mar 19, 2026 20:31 UTC Orthofix Medical Inc. OFIX · Entity 1975 SaleCommon Stock 4,269 $11.92 $50,886.48
Disclosure

SEC source: 0001193125-26-116071 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,449

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 127,256 previously reported restricted stock units.

Read SEC document
March 05, 2026 Filed Mar 6, 2026 21:19 UTC Orthofix Medical Inc. OFIX · Entity 1975 SaleCommon Stock 1,141 $12.55 $14,320.46
Disclosure

SEC source: 0001193125-26-096590 · ownership.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,718

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive.

F3 · balance_after: Includes 138,173 previously reported restricted stock units.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:19 UTC Orthofix Medical Inc. OFIX · Entity 1975 SaleCommon Stock 1,171 $12.92 $15,124.99
Disclosure

SEC source: 0001193125-26-096590 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,859

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

F3 · balance_after: Includes 138,173 previously reported restricted stock units.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 23:49 UTC Orthofix Medical Inc. OFIX · Entity 1975 GrantEmployee Stock Option (Right to Buy) · Derivative 45,546 $0.00 Strike: $13.03 $0.00
Disclosure

SEC source: 0001193125-26-094462 · ownership.xml · derivative · entry 2

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,546

Underlying: Common Stock · 45,546 shares

Expires 2033-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 23:49 UTC Orthofix Medical Inc. OFIX · Entity 1975 GrantCommon Stock 19,186 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-094462 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,030

F1 · shares: Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

F2 · balance_after: Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:21 UTC Orthofix Medical Inc. OFIX · Entity 1975 SaleCommon Stock 4,287 $16.60 $71,164.20
Disclosure

SEC source: 0000950170-25-042692 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BOO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,317

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 123,894 previously reported restricted stock units.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:19 UTC Orthofix Medical Inc. OFIX · Entity 1975 GrantEmployee Stock Option (Right to Buy) · Derivative 34,924 $0.00 Strike: $16.98 $0.00
Disclosure

SEC source: 0000950170-25-033620 · ownership.xml · derivative · entry 2

Vitale Lucas · CIK 0001763869 · CP&BO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,924

Underlying: Common Stock · 34,924 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:19 UTC Orthofix Medical Inc. OFIX · Entity 1975 GrantCommon Stock 14,723 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-033620 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,604

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 120,087 previously reported restricted stock units.

Read SEC document
May 07, 2021 Filed May 11, 2021 17:56 UTC NUVASIVE INC NUVA · Entity 110002 SaleCommon Stock 2,208 $68.23 $150,651.84
Disclosure

SEC source: 0001209191-21-031815 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,342

F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.

F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document
April 30, 2021 Filed May 4, 2021 17:54 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionRSUs · Derivative 3,054 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-030005 · doc4.xml · derivative · entry 4

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,054 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the RSU award, the award vested as to 3,054 shares on April 30, 2021.

F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the RSU award, the award vested as to 3,054 shares on April 30, 2021.

Read SEC document
April 30, 2021 Filed May 4, 2021 17:54 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionPRSUs · Derivative 321 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-030005 · doc4.xml · derivative · entry 3

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 321 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 321 shares on April 30, 2021.

F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 321 shares on April 30, 2021.

Read SEC document
April 30, 2021 Filed May 4, 2021 17:54 UTC NUVASIVE INC NUVA · Entity 110002 Tax withholdingCommon Stock 1,167 $71.45 $83,382.15
Disclosure

SEC source: 0001209191-21-030005 · doc4.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 191 shares acquired under the Issuer's employee stock purchase plan in April 2021.

Read SEC document
April 30, 2021 Filed May 4, 2021 17:54 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionCommon Stock 3,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-030005 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 191 shares acquired under the Issuer's employee stock purchase plan in April 2021.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 17:54 UTC NUVASIVE INC NUVA · Entity 110002 SaleCommon Stock 4,306 $68.19 $293,626.14
Disclosure

SEC source: 0001209191-21-026693 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,151

F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.

F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:55 UTC NUVASIVE INC NUVA · Entity 110002 GrantRSUs · Derivative 5,893 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-017156 · doc4.xml · derivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,893

Underlying: Common Stock · 5,893 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024.

F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024.

Read SEC document
February 10, 2021 Filed Feb 12, 2021 17:47 UTC NUVASIVE INC NUVA · Entity 110002 GrantPRSUs · Derivative 321 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-010335 · doc4.xml · derivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321

Underlying: Common Stock · 321 shares

Expires not disclosed

F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 321 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 321 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 17:50 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionRSUs · Derivative 386 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-044791 · doc4.xml · derivative · entry 3

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on August 1, 2018. In accordance with the terms of the RSU award, the award vested as to 386 shares on August 1, 2020.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on August 1, 2018. In accordance with the terms of the RSU award, the award vested as to 386 shares on August 1, 2020.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 17:50 UTC NUVASIVE INC NUVA · Entity 110002 Tax withholdingCommon Stock 133 $57.14 $7,599.62
Disclosure

SEC source: 0001209191-20-044791 · doc4.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,457

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 17:50 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionCommon Stock 386 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-044791 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020.

Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:53 UTC NUVASIVE INC NUVA · Entity 110002 GrantRSUs · Derivative 4,953 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015526 · doc4.xml · derivative · entry 4

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,953

Underlying: Common Stock · 4,953 shares

Expires not disclosed

F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F5 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023.

F5 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 17:53 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionRSUs · Derivative 1,652 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015526 · doc4.xml · derivative · entry 3

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,652 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the RSU award, the award vested as to 1,652 shares on March 1, 2020.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the RSU award, the award vested as to 1,652 shares on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 17:53 UTC NUVASIVE INC NUVA · Entity 110002 Tax withholdingCommon Stock 633 $65.81 $41,657.73
Disclosure

SEC source: 0001209191-20-015526 · doc4.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,850

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 436 shares acquired under the Issuer's employee stock purchase plan in April 2019.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 17:53 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionCommon Stock 1,652 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015526 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 436 shares acquired under the Issuer's employee stock purchase plan in April 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:55 UTC NUVASIVE INC NUVA · Entity 110002 GrantRSUs · Derivative 5,130 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 5

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,130

Underlying: Common Stock · 5,130 shares

Expires not disclosed

F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F7 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022.

F7 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:55 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionRSUs · Derivative 3,001 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 4

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the RSU award, the award vested as to 3,001 shares on March 1, 2019.

F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the RSU award, the award vested as to 3,001 shares on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:55 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionPRSUs · Derivative 991 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 3

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 991 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 991 shares on March 1, 2019.

F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 991 shares on March 1, 2019.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:55 UTC NUVASIVE INC NUVA · Entity 110002 Tax withholdingCommon Stock 1,404 $58.48 $82,105.92
Disclosure

SEC source: 0001209191-19-016854 · doc4.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,395

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:55 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionCommon Stock 3,992 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016854 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document
February 06, 2019 Filed Feb 7, 2019 18:02 UTC NUVASIVE INC NUVA · Entity 110002 GrantPRSUs · Derivative 991 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-008201 · doc4.xml · derivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 991

Underlying: Common Stock · 991 shares

Expires not disclosed

F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 991 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 991 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

Read SEC document
February 01, 2019 Filed Feb 4, 2019 18:03 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionRSUs · Derivative 731 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-006921 · doc4.xml · derivative · entry 3

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 731 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the RSU award, the award vested as to 732 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 731 shares on February 1, 2019.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the RSU award, the award vested as to 732 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 731 shares on February 1, 2019.

Read SEC document
February 01, 2019 Filed Feb 4, 2019 18:03 UTC NUVASIVE INC NUVA · Entity 110002 Tax withholdingCommon Stock 298 $49.13 $14,640.74
Disclosure

SEC source: 0001209191-19-006921 · doc4.xml · nonDerivative · entry 2

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,807

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document
February 01, 2019 Filed Feb 4, 2019 18:03 UTC NUVASIVE INC NUVA · Entity 110002 Exercise / conversionCommon Stock 731 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-006921 · doc4.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,105

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.